Loading...

PETROS PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

PTRS

PETROS PHARMACEUTICALS INC

()

2025 8-K

Show Summary

Summary

Management Change

Voluntary Bankruptcy

Voluntary Delisting

Reverse Stock Split

Delisting Notice

Accountant Change

Public Offering

Capital Structure Change

Annual Meeting Results

Management Changes

Capital Structure Change

Director Resignations

Annual Meeting Notice

Agreement and Amendment

Dismissal of Independent Re...

Annual Meeting of Stockholders

Management Grants

Stock Increase Amendment

Amendment to By-laws

External Links:

Petros Pharmaceuticals entered into an agreement to sell Series A Convertible Preferred Stock and warrants to investors, extending payment deadlines and modifying terms related to its business strategy and cash requirements.

AI Assistant

PETROS PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.